Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXM1JF
|
||||
| Drug Name |
4-fluorophenyl N-{19-methyl-14-oxo-3-propyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-7-yl}carbamate
|
||||
| Synonyms |
CHEMBL265284
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H26FN5O3
|
||||
| Canonical SMILES |
CCCn1c2ccc(NC(=O)Oc3ccc(F)cc3)cc2c4c5CNC(=O)c5c6c(CCc7nn(C)cc67)c14
|
||||
| InChI |
InChI=1S/C30H26FN5O3/c1-3-12-36-24-11-6-17(33-30(38)39-18-7-4-16(31)5-8-18)13-20(24)26-21-14-32-29(37)27(21)25-19(28(26)36)9-10-23-22(25)15-35(2)34-23/h4-8,11,13,15H,3,9-10,12,14H2,1-2H3,(H,32,37)(H,33,38)
|
||||
| InChIKey |
JBZOYVITNJEWFR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.